ENP104: Hidden Ingredients in Supplements

About this episode

The episode discusses the lack of regulation in supplement ingredients and features an interview with Dr. Meghana Pattipati about her study on hidden ingredients affecting endocrine health.

In the United States, the Food and Drug Administration doesn’t regulate supplements for safety and efficacy, so manufacturers don’t have to disclose their ingredients. We can’t always know for certain what’s in supplements we buy over the counter. Host Aaron Lohr talks with Meghana Pattipati, MD , an endocrine specialist at Ochsner Lafayette General Medical Center in Louisiana. Dr. Pattipati presented a study at ENDO 2025 in San Francisco titled, “Beware of the Hidden Ingredients and Supplement Use in Your Patients With Elevated Testosterone.” The presentation describes a case where a patient unknowingly ingested an ingredient that had a significant endocrine impact. Show notes are available at https://www.endocrine.org/podcast/enp104 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

People in this episode

Host: Aaron Lohr

Guest: Meghana Pattipati, MD

Topics covered

• supplements
• endocrine health
• FDA regulation
• ingredient safety
• testosterone

Keywords

• supplements
• FDA
• endocrine impact
• testosterone
• health safety

Mentioned in this episode

Organizations: Ochsner Lafayette General Medical Center, Food and Drug Administration

Places: San Francisco

More episodes of Endocrine News Podcast

• ENP111: Addressing the Endocrine Workforce Shortage · February 25, 2026 · 30 min
• ENP110: Hypercortisolism and T2D · January 21, 2026 · 20 min
• ENP109: Anti-Obesity Medications (CME credit available) · January 7, 2026 · 13 min
• ENP108: AI and Robotics in Surgery · December 17, 2025 · 10 min
• ENP107: Compounded Obesity Medications · December 3, 2025 · 12 min
• ENP106: Reversing Bariatric Surgery · November 12, 2025 · 12 min